Goldman Sachs Resumes Ryland Group (RYL) at Conviction Buy
Tweet
Share
E-mail
Get Alerts RYL Hot Sheet
Price: $40.83 --0%
Rating Summary:
11 Buy, 9 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 5 | Down: 11 | New: 27
Rating Summary:
11 Buy, 9 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 5 | Down: 11 | New: 27
Join SI Premium – FREE
Goldman Sachs resumes coverage on Ryland Group (NYSE: RYL) with a Conviction Buy List rating and $51 price target.
"The company ranks first on our themes, with presence in most constructive housing markets, a strong land portfolio, and relatively good exposure to the high-end buyer," the analyst said. "Further, we believe Ryland has one of the best capital structures in our coverage leading to a peer-high ROE of 21.5% for 2013."
Goldman notes Ryland has a strong presence in the Charlotte, Orlando, Phoenix, and Indianapolis markets, the strongest markets in terms of pricing strength, household formation, and job growth.
For an analyst ratings summary and ratings history on Ryland Group click here. For more ratings news on Ryland Group click here.
Shares of Ryland Group closed at $38.56 yesterday.
"The company ranks first on our themes, with presence in most constructive housing markets, a strong land portfolio, and relatively good exposure to the high-end buyer," the analyst said. "Further, we believe Ryland has one of the best capital structures in our coverage leading to a peer-high ROE of 21.5% for 2013."
Goldman notes Ryland has a strong presence in the Charlotte, Orlando, Phoenix, and Indianapolis markets, the strongest markets in terms of pricing strength, household formation, and job growth.
For an analyst ratings summary and ratings history on Ryland Group click here. For more ratings news on Ryland Group click here.
Shares of Ryland Group closed at $38.56 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- CFRA Starts SpaceX (SPCX) at Sell, 'Our primary concern is that SpaceX’s long-term strategy remains heavily dependent on Starship'
- Adobe (ADBE) PT Lowered to $225 at UBS Amid Plans to Pivot to Freemium Model
- BofA Securities Starts Avalo Therapeutics Inc. (AVTX) at Buy
Create E-mail Alert Related Categories
Analyst Comments, Hot New Coverage, New CoverageRelated Entities
Goldman Sachs Conviction Buy List, Goldman SachsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
